Donepezil and concurrent sertraline treatment is associated with increased hippocampal volume in a patient with depression.
Suda
Shiro
S
Sugihara
Genichi
G
Suyama
Rie
R
Mori
Norio
N
Takei
Nori
N
D000328:Adult; D000544:Alzheimer Disease / Q000175:diagnosis; D001284:Atrophy; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000473:pathology / Q000523:psychology; D003937:Diagnosis, Differential; D000077265:Donepezil; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D007839:Functional Laterality; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D010880:Piperidines / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D020280:Sertraline / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D000077265:Donepezil; D007189:Indans; D010880:Piperidines; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline